HBM contact: Dr Michael Buschle
Company status: private
Biopharma is a clinical stage company focused on identifying and developing
potent and specific immune modulation molecules. The two lead assets of the
company are in clincal trials in atopic dermatitis and ulcerative colitis.
Additional indications will be explored in the future.